3 things about the Vanguard Australian Shares Index ETF (VAS) every smart investor knows  

This fund has a number of interesting characteristics. Here's what I'm focused on.

| More on:
A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Vanguard Australian Shares Index ETF (ASX: VAS) is the most popular exchange-traded fund (ETF) in terms of how much money is invested in it.

This fund tracks the S&P/ASX 300 Index (ASX: XKO), being 300 of the largest businesses on the ASX.

Most people already know that ASX ETFs can be useful for diversification, but there are other elements that I think investors need to be even more aware of. So, let's get into it.

One of the cheapest ASX ETFs

Investors can't control what the return of the index will be, but they can choose what management fee they want to sign up for.

The higher the fees, the smaller the net return is for investors, so identifying funds with lower fees helps keep more wealth in the hands of investors.

The VAS ETF isn't the cheapest fund that focuses on ASX shares. But its costs are virtually the same as those of the BetaShares Australia 200 ETF (ASX: A200). The VAS ETF has an annual management fee of just 0.07%.

Having the lowest costs isn't the only thing to focus on, but for an index-tracking ETF, I think it measures up well against competitors.

Big dividend yield

This fund isn't known for delivering a high level of capital growth in most years. However, it is likely to deliver investors a pleasing level of passive income because of the generous dividend payout ratios from the major dividend payers in the index.

I'm talking about businesses like Commonwealth Bank of Australia (ASX: CBA), BHP Group Ltd (ASX: BHP), Westpac Banking Corp (ASX: WBC), National Australia Bank Ltd (ASX: NAB), Wesfarmers Ltd (ASX: WES), ANZ Group Holdings Ltd (ASX: ANZ), Macquarie Group Ltd (ASX: MQG), and Telstra Group Ltd (ASX: TLS).

According to Vanguard, at the end of April 2025, it had a (partially franked) dividend yield of 3.4%. To me, that's a lot better than what international share-focused ETFs typically offer.

Relatively low return on equity

In my opinion, businesses with a low return on equity (ROE) are usually less appealing to own than those with a high ROE.

A low ROE means they're not generating as much profit for the amount of shareholder money retained within the business. The higher the ROE, the higher the quality of the business.

The ROE also suggests the business may make that level of return on reinvested money; therefore, the higher the ROE, the better for future shareholder returns.

According to Vanguard, the VAS ETF had an ROE of 12.4%. Compare that to another Vanguard offering – the Vanguard MSCI International Shares Index ETF (ASX: VGS), which has an ROE of 19.2%.

While the ROE doesn't automatically translate into how much the share price will rise, it doesn't surprise me that the VGS ETF has delivered an average annual return that's 4% higher than the VAS ETF.

ASX shares are great and definitely worth a spot in our portfolios, but I think it's also important to acknowledge that there are many great businesses outside of the ASX that are worth having exposure to in one way or another.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Wesfarmers. The Motley Fool Australia has positions in and has recommended Macquarie Group and Telstra Group. The Motley Fool Australia has recommended BHP Group, Vanguard Msci Index International Shares ETF, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

The letters ETF sit in orange on top of a chart with a magnifying glass held over the top of it.
ETFs

How did the Vanguard Australian Shares Index ETF go in FY25?

Investors in Australia's biggest ASX ETF enjoyed solid returns last financial year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
ETFs

Top ASX ETFs to supercharge your portfolio in FY26

Let's see what could make these funds top picks for Aussie investors in the new financial year.

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs and scientific symbols as she smiles.
ETFs

Is there a Magnificent 7 ASX ETF?

Nvidia just became the world's first US$4 trillion company.

Read more »

Man looking at an ETF diagram.
ETFs

These Vanguard ASX ETFs rose more than 15% in the last year

This ETF provider has had some winning funds in the last 12 months. 

Read more »

Five happy friends on their phones.
ETFs

3 ASX tech ETFs with serious upside potential

Let's take a closer look at these exciting funds.

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
ETFs

5 ASX ETFs to buy with $10,000 today

These funds could be worth a deeper dive. Let's see what they offer.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
ETFs

Why S&P 500 focused IVV ETF isn't as diversified as you might think

Is the IVV ETF a risky investment today?

Read more »

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
ETFs

The long game: ASX ETFs to target amidst an ageing population

These funds could be set to benefit from increased demand in global healthcare. 

Read more »